Point source concentration of GDNF may explain failure of phase II clinical trial
Year: 2006
Type: article
Source: Experimental Neurology
Authors: M SALVATORE, Y AI, B FISCHER, A ZHANG, R GRONDIN, Z ZHANG, G GERHARDT, D GASH
Institution: University of Kentucky
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Amgen
OpenAlex ID: W2019695510